Department of Chemical and Chemical Engineering, Hefei Normal University, Hefei, 230601, People's Republic of China.
Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, People's Republic of China; University of Chinese Academy of Sciences, Beijing 100049, People's Republic of China.
J Pharm Biomed Anal. 2020 Nov 30;191:113600. doi: 10.1016/j.jpba.2020.113600. Epub 2020 Sep 9.
Seven impurities were detected in doramectin bulk drug by HPLC analysis. These impurities were named as Imp-I, Imp-II, Imp-III, Imp-IV, Imp-V, Imp-VI, and Imp-VII. All impurities were isolated from doramectin bulk drug by means of preparative HPLC. Among impurities, Imp-IV and Imp-V were unknown and have not been reported previously. Based on the complete spectral analysis, including 1D (H, C, H-D, DEPT 90 and 135), 2D (COSY, HSQC, HMBC, and NOESY) NMR, IR, and ESI-HRMS, the structure of Imp-IV and Imp-V were elucidated. Imp-IV was found to be a furan ring-opening product, while Imp-V lacked a methyl group at the C-14 in doramectin. Identification, isolation, structural characterization, probable formation mechanism, and insecticidal activity of impurities of doramectin were also discussed.
高效液相色谱法分析发现多拉菌素原料药中有 7 种杂质。这些杂质分别命名为 Imp-I、Imp-II、Imp-III、Imp-IV、Imp-V、Imp-VI 和 Imp-VII。所有杂质均通过制备高效液相色谱法从多拉菌素原料药中分离得到。其中杂质 Imp-IV 和 Imp-V 是未知的,以前没有报道过。基于包括 1D(H、C、H-D、DEPT 90 和 135)、2D(COSY、HSQC、HMBC 和 NOESY)NMR、IR 和 ESI-HRMS 在内的完整光谱分析,阐明了 Imp-IV 和 Imp-V 的结构。发现 Imp-IV 是呋喃环开裂产物,而 Imp-V 缺少多拉菌素 C-14 位上的甲基。还讨论了多拉菌素杂质的鉴定、分离、结构表征、可能的形成机制和杀虫活性。